|
Mar 14
|
Q4 2024 Heartbeam Inc Earnings Call
|
|
Mar 14
|
HeartBeam Inc (BEAT) Q4 2024 Earnings Call Highlights: FDA Clearance and Strategic Moves
|
|
Mar 13
|
HeartBeam Reports Fourth Quarter and Full Year 2024 Results
|
|
Feb 27
|
HeartBeam to Host Fourth Quarter Full Year 2024 Results Conference Call on Thursday, March 13, 2025 at 4:30 p.m. Eastern Time
|
|
Feb 25
|
HeartBeam Announces Exercise and Closing of Underwriter’s Over-Allotment Option for Public Offering of Common Stock
|
|
Sep 24
|
HeartBeam Appoints Dr. Lance Myers as Chief AI Scientist
|
|
May 21
|
HeartBeam’s AI device outperforms experts in detecting atrial flutter
|
|
May 20
|
HeartBeam’s Artificial Intelligence Algorithm Combined with Vectorcardiography (VCG) Outperforms Expert Cardiologists in Detecting Arrhythmias
|
|
Dec 28
|
Insiders Of HeartBeam Are Up 49% On Their US$2.89m Purchase
|
|
Nov 15
|
HeartBeam, Inc. (NASDAQ:BEAT) Q3 2023 Earnings Call Transcript
|
|
Nov 14
|
HeartBeam Reports Third Quarter 2023 Financial Results
|
|
Nov 9
|
HeartBeam Announces Expansion of Its Scientific Advisory Board
|
|
Nov 7
|
HeartBeam Granted Third US Patent for 12-Lead Extended Wear Patch for Detecting Heart Attacks and Complex Cardiac Arrythmias
|
|
Aug 11
|
Q2 2023 Heartbeam Inc Earnings Call
|
|
Aug 10
|
HeartBeam Reports Second Quarter 2023 Financial Results
|
|
Aug 9
|
HeartBeam Announces Publication of Foundational Study on the Detection of Heart Attacks
|
|
Aug 8
|
HeartBeam Appoints Deborah Castillo as Vice President of Regulatory Affairs
|
|
May 3
|
HeartBeam Completes $25 Million Capital Raise and Updates 2023 Strategic Focus and Financial Guidance
|